Terms: = Lymphoma AND POU2AF1, OBF1, 5450, ENSG00000110777, BOB1, OCAB, Q16633, OBF-1
85 results:
1. Transcriptional Coactivator bob1 (obf1, OCA-B) Modulates the Specificity of DNA Recognition by the POU-Domain Factors OCT1 and OCT2 in a Monomeric Configuration.
Nazarov IB; Zilov DS; Gordeev MN; Potapenko EV; Yeremenko N; Tomilin AN
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254723
[TBL] [Abstract] [Full Text] [Related]
2. Validation of genes for H-ARS severity prediction in leukemia patients - interspecies comparison, challenges, and promises.
Schwanke D; Valente M; Ostheim P; Schüle S; Bobyk L; Drouet M; Riccobono D; Magné N; Daguenet E; Stewart SJ; Muhtadi R; Port M; Abend M
Int J Radiat Biol; 2024; 100(4):527-540. PubMed ID: 38227483
[TBL] [Abstract] [Full Text] [Related]
3. [Progressively transformed germinal center-like follicular T-cell lymphoma:a clinicopathological analysis of 14 cases].
Zheng YY; Xie JL; Zhang YL; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2023 Nov; 52(11):1144-1150. PubMed ID: 37899321
[No Abstract] [Full Text] [Related]
4. [Mutational Spectrum and Prognosis Analysis of Young Patients with Diffuse Large B-Cell lymphoma Based on Next-Generation Sequencing].
Lyu LY; Nie YL; Renaguli A; Qi XL; Muhebaier A; Zhai SS; An L; Mao M; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):403-410. PubMed ID: 37096512
[TBL] [Abstract] [Full Text] [Related]
5. Losing CD45 and various B-cell markers in a case of MYC-driven pediatric high-grade B-cell lymphoma, not otherwise specified that transformed from Burkitt's lymphoma during rituximab-containing treatments: a case report.
Xue X; Fu L; Qiu T; Cao Z; Wang X; Rao W; Luo Y; He L; Feng X
Virchows Arch; 2023 Jul; 483(1):111-116. PubMed ID: 36383247
[TBL] [Abstract] [Full Text] [Related]
6. [ALK-positive large B-cell lymphoma with EBV infection or cyclin D1 expression: a clinicopathological analysis of 3 cases].
Wu WN; Xiang CX; Ma DS; Liu GZ; Liu H
Zhonghua Bing Li Xue Za Zhi; 2022 Jun; 51(6):506-511. PubMed ID: 35673721
[No Abstract] [Full Text] [Related]
7. ALK-positive Large B-Cell lymphoma Presenting as a Circumscribed Breast Mass with Germinal Center Immunophenotype.
Yan M; Khattab R; Meyerson H
Int J Surg Pathol; 2023 Apr; 31(2):233-238. PubMed ID: 35521914
[TBL] [Abstract] [Full Text] [Related]
8. A Comprehensive Clinicopathologic and Molecular Study of 19 Primary Effusion lymphomas in HIV-infected Patients.
Calvani J; Gérard L; Fadlallah J; Poullot E; Galicier L; Robe C; Garzaro M; Bertinchamp R; Boutboul D; Cuccuini W; Cayuela JM; Gaulard P; Oksenhendler É; Meignin V
Am J Surg Pathol; 2022 Mar; 46(3):353-362. PubMed ID: 34560683
[TBL] [Abstract] [Full Text] [Related]
9. Lymphocyte-depleted classic Hodgkin lymphoma with primary extranodal disease: Two cases that highlight the combination of immunodeficiency and immune escape in the pathogenesis.
Tsuyuki Y; Kohno K; Inagaki Y; Sakai Y; Kosugi H; Takahashi E; Suzuki Y; Shimada S; Kato S; Takahara T; Satou A; Shimoyama Y; Nakamura S; Asano N; Sakakibara A
J Clin Exp Hematop; 2021; 61(3):173-179. PubMed ID: 34511545
[TBL] [Abstract] [Full Text] [Related]
10. Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B-cell lymphoma.
Napoli S; Cascione L; Rinaldi A; Spriano F; Guidetti F; Zhang F; Cacciapuoti MT; Mensah AA; Sartori G; Munz N; Forcato M; Bicciato S; Chiappella A; Ghione P; Elemento O; Cerchietti L; Inghirami G; Bertoni F
Haematologica; 2022 May; 107(5):1131-1143. PubMed ID: 34162177
[TBL] [Abstract] [Full Text] [Related]
11. Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK + LBCL): a systematic review of clinicopathological features and management.
Castillo JJ; Beltran BE; Malpica L; Marques-Piubelli ML; Miranda RN
Leuk Lymphoma; 2021 Dec; 62(12):2845-2853. PubMed ID: 34151703
[TBL] [Abstract] [Full Text] [Related]
12. obf1 and Oct factors control the germinal center transcriptional program.
Song S; Cao C; Choukrallah MA; Tang F; Christofori G; Kohler H; Wu F; Fodor BD; Frederiksen M; Willis SN; Jackson JT; Nutt SL; Dirnhofer S; Stadler MB; Matthias P
Blood; 2021 May; 137(21):2920-2934. PubMed ID: 33512466
[TBL] [Abstract] [Full Text] [Related]
13. Unique Immune Cell Coactivators Specify Locus Control Region Function and Cell Stage.
Chu CS; Hellmuth JC; Singh R; Ying HY; Skrabanek L; Teater MR; Doane AS; Elemento O; Melnick AM; Roeder RG
Mol Cell; 2020 Dec; 80(5):845-861.e10. PubMed ID: 33232656
[TBL] [Abstract] [Full Text] [Related]
14. Syncytial variant of classic Hodgkin lymphoma: Four cases diagnosed with the aid of CD274/programmed cell death ligand 1 immunohistochemistry.
Kohno K; Sakakibara A; Iwakoshi A; Hasegawa M; Adachi S; Ishikawa E; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Takahashi E; Ohashi A; Satou A; Kato S; Asano N; Nakamura S
Pathol Int; 2020 Feb; 70(2):108-115. PubMed ID: 31894892
[TBL] [Abstract] [Full Text] [Related]
15. EBV-Positive Primary Large B-Cell lymphoma: The Role of Immunohistochemistry and XPO1 in the Diagnosis of Mediastinal lymphomas.
Maracaja DLV; Puthenpura V; Pels SG; O'Malley DP; Sklar JL; Finberg KE; Xu ML
Appl Immunohistochem Mol Morphol; 2020; 28(10):725-730. PubMed ID: 31789821
[TBL] [Abstract] [Full Text] [Related]
16. American Registry of Pathology Expert Opinions: Immunohistochemical evaluation of classic Hodgkin lymphoma.
O'Malley DP; Dogan A; Fedoriw Y; Medeiros LJ; Ok CY; Salama ME
Ann Diagn Pathol; 2019 Apr; 39():105-110. PubMed ID: 30802809
[TBL] [Abstract] [Full Text] [Related]
17. Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma.
González-Rincón J; Méndez M; Gómez S; García JF; Martín P; Bellas C; Pedrosa L; Rodríguez-Pinilla SM; Camacho FI; Quero C; Pérez-Callejo D; Rueda A; Llanos M; Gómez-Codina J; Piris MA; Montes-Moreno S; Bárcena C; Rodríguez-Abreu D; Menárguez J; de la Cruz-Merino L; Monsalvo S; Parejo C; Royuela A; Kwee I; Cascione L; Arribas A; Bertoni F; Mollejo M; Provencio M; Sánchez-Beato M
PLoS One; 2019; 14(2):e0212813. PubMed ID: 30802265
[TBL] [Abstract] [Full Text] [Related]
18. Gray-zone lymphoma Between cHL and Large B-Cell lymphoma: A Histopathologic Series From the LYSA.
Sarkozy C; Copie-Bergman C; Damotte D; Ben-Neriah S; Burroni B; Cornillon J; Lemal R; Golfier C; Fabiani B; Chassagne-Clément C; Parrens M; Herbaux C; Xerri L; Bossard C; Laurent C; Cheminant M; Cartron G; Cabecadas J; Molina T; Salles G; Steidl C; Ghesquières H; Mottok A; Traverse-Glehen A
Am J Surg Pathol; 2019 Mar; 43(3):341-351. PubMed ID: 30540571
[TBL] [Abstract] [Full Text] [Related]
19. Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2.
Takimoto-Shimomura T; Tsukamoto T; Maegawa S; Fujibayashi Y; Matsumura-Kimoto Y; Mizuno Y; Chinen Y; Shimura Y; Mizutani S; Horiike S; Taniwaki M; Kobayashi T; Kuroda J
Invest New Drugs; 2019 Apr; 37(2):210-222. PubMed ID: 29931583
[TBL] [Abstract] [Full Text] [Related]
20. Successful treatment of primary bone marrow Hodgkin lymphoma with brentuximab vedotin: a case report and review of the literature.
Nagaharu K; Masuya M; Kageyama Y; Yamaguchi T; Ito R; Kawakami K; Ito M; Katayama N
J Med Case Rep; 2018 May; 12(1):151. PubMed ID: 29843820
[TBL] [Abstract] [Full Text] [Related]
[Next]
